West Newton, MA, United States of America

Joyce A Sutcliffe

USPTO Granted Patents = 12 (Patent Applications = 8)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 5.7

ph-index = 5

Forward Citations = 57(Granted Patents)

Location History:

Branford, CT (US) (2006)
Brandford, CT (US) (2008)
Clinton, CT (US) (2010 - 2014)
Newton, MA (US) (2016 - 2017)
West Newton, MA (US) (2012 - 2020)

Company Filing History:

5 out of 17

Rib-x Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals, Inc.

patents

5. 2 out of 23

Melinta Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2006-2020

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10525121 - Nanoemulsion influenza vaccine (2020-01-07),

2. 9624166 - Tetracycline compounds (2017-04-18),

3. 9371283 - Polycyclic tetracycline compounds (2016-06-21),

4. 9144606 - Nanoemulsion influenza vaccine (2015-09-29),

5. 8912150 - Ribosome structure and protein synthesis inhibitors (2014-12-16),

6. 8841263 - Macrocyclic compounds and methods of making and using the same (2014-09-23),

7. 8470990 - Ribosome structure and protein synthesis inhibitors (2013-06-25),

8. 8226965 - Methods of treating fungal, yeast and mold infections (2012-07-24),

9. 8202843 - Macrocyclic compounds and methods of making and using the same (2012-06-19),

10. 7666849 - Ribosome structure and protein synthesis inhibitors (2010-02-23),

11. 7335753 - Bifunctional heterocyclic compounds and methods of making and using same (2008-02-26),

12. 7091196 - Bifunctional heterocyclic compounds and methods of making and using same (2006-08-15),

Title: The Innovative Journey of Joyce A. Sutcliffe

Introduction: Joyce A. Sutcliffe, an accomplished inventor based in West Newton, MA, has made significant contributions to the field of immunology through her pioneering work in vaccine development. With a remarkable portfolio of 10 patents, she has dedicated her career to advancing healthcare solutions that improve the immune response to various diseases.

Latest Patents: Among her notable inventions is the innovative nanoemulsion influenza vaccine. This cutting-edge technology focuses on methods for inducing an immune response to influenza by administering a nanoemulsion vaccine composition that incorporates an influenza immunogen or protein. By leveraging advanced nanotechnology, Joyce's work aims to enhance the efficacy of vaccines, offering new hope in the fight against influenza.

Career Highlights: Joyce A. Sutcliffe has cultivated a distinguished career, notably working with leading companies such as Rib-X Pharmaceuticals, Inc. and Nanobio Corporation. Her experience in these organizations has allowed her to translate scientific research into practical applications, further cementing her reputation as a leader in the field of vaccine innovation.

Collaborations: Throughout her career, Joyce has collaborated with esteemed colleagues, including Adegboyega K. Oyelere and Joseph A. Ippolito. These partnerships have not only enriched her work but also fostered a collaborative spirit that is essential for driving innovation in scientific research and development.

Conclusion: Joyce A. Sutcliffe’s contributions to the field of immunology through her patents and collaborative efforts exemplify the spirit of innovation. As she continues to push the boundaries of vaccine technology, her work serves as an inspiration for future inventors and researchers dedicated to making impactful advances in healthcare.

This text is generated by artificial intelligence and may not be accurate.